Agassi Sports Entertainment Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Agassi Sports Entertainment Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $2.02M | Mar 30, 2016 |
| FY2015 | Dec 31, 2014 | $2.13M | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $2.09M | Mar 30, 2015 |
| FY2013 | Dec 31, 2012 | $2.13M | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | $2.12M | Apr 1, 2013 |
| FY2011 | Dec 31, 2010 | $1.96M | Mar 23, 2012 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $1.93M | Mar 31, 2014 |
| FY2012 | Dec 31, 2012 | $1.97M | Apr 1, 2013 |
| FY2012 | Dec 31, 2011 | $1.96M | Apr 1, 2013 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $1.40M | Mar 30, 2016 |
| FY2015 | Dec 31, 2014 | $1.46M | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $1.34M | Mar 30, 2015 |
| FY2013 | Dec 31, 2012 | $1.40M | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | $1.48M | Apr 1, 2013 |
| FY2011 | Dec 31, 2010 | $1.27M | Mar 23, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($9.49M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($793.7K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($69.9K) | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | ($57.4K) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($98.4K) | Mar 22, 2023 |
| FY2021 | Dec 31, 2020 | ($70.8K) | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | ($83.8K) | Apr 1, 2021 |
| FY2018 | Dec 31, 2018 | $80.8K | Apr 1, 2019 |
| FY2017 | Dec 31, 2017 | $86.0K | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $628.0K | Apr 2, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($793.7K) | Mar 26, 2025 |
| FY2024 | Dec 31, 2023 | ($69.9K) | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | ($57.4K) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($98.4K) | Mar 22, 2023 |
| FY2021 | Dec 31, 2020 | ($70.8K) | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | ($83.8K) | Apr 1, 2021 |
| FY2019 | Dec 31, 2018 | ($80.8K) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($86.0K) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($355.6K) | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | ($354.7K) | Apr 17, 2017 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $70.8K | Apr 1, 2021 |
| FY2020 | Dec 31, 2019 | $83.8K | Apr 1, 2021 |
| FY2019 | Dec 31, 2018 | $80.7K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $85.7K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $354.5K | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $352.8K | Apr 17, 2017 |
| FY2015 | Dec 31, 2014 | $1.44M | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $1.50M | Mar 30, 2015 |
| FY2013 | Dec 31, 2012 | $1.57M | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | $1.49M | Apr 1, 2013 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.20M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($149.4K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($56.2K) | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | ($59.6K) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($109.8K) | Mar 22, 2023 |
| FY2021 | Dec 31, 2020 | ($81.0K) | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | ($64.0K) | Apr 1, 2021 |
| FY2019 | Dec 31, 2018 | ($78.1K) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($97.5K) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($319.5K) | Apr 2, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2024 | $10.1K | Mar 31, 2026 |
| FY2015 | Dec 31, 2015 | $36.2K | Mar 30, 2016 |
| FY2015 | Dec 31, 2014 | $50.5K | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $76.1K | Mar 30, 2015 |
| FY2013 | Dec 31, 2012 | $144.8K | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | $83.1K | Apr 1, 2013 |
| FY2011 | Dec 31, 2010 | ($37.1K) | Mar 23, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $800.4K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $2.33M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $38 | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | $38 | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $64 | Mar 22, 2023 |
| FY2021 | Dec 31, 2020 | $69 | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | $37 | Apr 1, 2021 |
| FY2019 | Dec 31, 2018 | $14.2K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $28.5K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $344 | Apr 2, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $306.0K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $2.28M | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | ($610.2K) | Mar 31, 2026 |
| FY2024 | Jan 30, 2023 | ($540.4K) | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | ($540.4K) | Mar 29, 2024 |
| FY2023 | Dec 31, 2021 | ($482.9K) | Mar 29, 2024 |
| FY2022 | Dec 31, 2020 | ($384.6K) | Mar 22, 2023 |
| FY2021 | Dec 31, 2019 | ($313.8K) | Mar 8, 2022 |
| FY2020 | Dec 31, 2018 | ($229.9K) | Apr 1, 2021 |
| FY2019 | Dec 31, 2017 | ($149.2K) | Mar 30, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($39.63M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($30.14M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($29.34M) | Mar 26, 2025 |
| FY2023 | Dec 31, 2022 | ($29.27M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($29.22M) | Mar 22, 2023 |
| FY2021 | Sep 30, 2021 | ($29.22M) | Mar 8, 2022 |
| FY2021 | Dec 31, 2020 | ($29.12M) | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | ($29.05M) | Apr 1, 2021 |
| FY2019 | Dec 31, 2018 | ($28.96M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($28.88M) | Apr 1, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $95.7K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $2.32M | Mar 31, 2026 |
| FY2015 | Dec 31, 2015 | $5.9K | Mar 30, 2016 |
| FY2015 | Dec 31, 2014 | $2.2K | Mar 30, 2016 |
| FY2015 | Dec 31, 2013 | $0 | Mar 30, 2016 |
| FY2014 | Dec 31, 2012 | $5.5K | Mar 30, 2015 |
| FY2013 | Dec 31, 2011 | $1.9K | Mar 31, 2014 |
| FY2012 | Dec 31, 2010 | $10.6K | Apr 1, 2013 |
| FY2011 | Dec 31, 2009 | $272.8K | Mar 23, 2012 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9.79M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 9.79M | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | 5.66M | Mar 31, 2026 |
| FY2023 | Dec 31, 2022 | 5.66M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | 5.66M | Mar 22, 2023 |
| FY2021 | Dec 31, 2020 | 5.66M | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | 5.66M | Apr 1, 2021 |
| FY2019 | Dec 31, 2018 | 5.62M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 5.66M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 5.62M | Apr 2, 2018 |